MAGNI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 16.456
AS - Asia 11.723
EU - Europa 9.861
SA - Sud America 1.714
AF - Africa 367
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 27
Totale 40.178
Nazione #
US - Stati Uniti d'America 16.034
CN - Cina 5.740
SG - Singapore 2.568
IE - Irlanda 2.251
IT - Italia 1.303
BR - Brasile 1.302
RU - Federazione Russa 1.184
HK - Hong Kong 1.115
DE - Germania 1.065
VN - Vietnam 1.052
UA - Ucraina 989
FI - Finlandia 895
FR - Francia 624
GB - Regno Unito 500
SE - Svezia 457
IN - India 315
CA - Canada 226
ZA - Sudafrica 213
AR - Argentina 160
BD - Bangladesh 133
MX - Messico 130
IQ - Iraq 111
BE - Belgio 107
JP - Giappone 102
PL - Polonia 86
NL - Olanda 79
ES - Italia 73
TR - Turchia 69
EC - Ecuador 68
CO - Colombia 59
PK - Pakistan 58
AT - Austria 50
IR - Iran 45
ID - Indonesia 44
VE - Venezuela 42
MA - Marocco 38
UZ - Uzbekistan 38
SA - Arabia Saudita 37
CH - Svizzera 34
MY - Malesia 33
CZ - Repubblica Ceca 32
CL - Cile 31
PH - Filippine 30
JO - Giordania 26
LT - Lituania 23
EU - Europa 22
AU - Australia 21
NP - Nepal 20
IL - Israele 19
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 17
GR - Grecia 17
EG - Egitto 16
ET - Etiopia 16
KZ - Kazakistan 16
PE - Perù 16
DO - Repubblica Dominicana 14
BO - Bolivia 13
KE - Kenya 13
KR - Corea 13
RO - Romania 13
DZ - Algeria 12
LV - Lettonia 12
TH - Thailandia 12
AL - Albania 11
JM - Giamaica 11
UY - Uruguay 11
PY - Paraguay 10
PS - Palestinian Territory 9
QA - Qatar 9
AM - Armenia 8
CR - Costa Rica 8
LB - Libano 8
OM - Oman 8
HR - Croazia 7
KG - Kirghizistan 7
LK - Sri Lanka 7
NZ - Nuova Zelanda 7
BG - Bulgaria 6
HU - Ungheria 6
NI - Nicaragua 6
SN - Senegal 6
BB - Barbados 5
GE - Georgia 5
KW - Kuwait 5
NG - Nigeria 5
PT - Portogallo 5
RS - Serbia 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
DK - Danimarca 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
PA - Panama 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
GT - Guatemala 3
Totale 40.105
Città #
Dublin 2.247
Chandler 2.067
San Jose 1.622
Dallas 1.461
Singapore 1.456
Ashburn 1.372
Jacksonville 1.304
Nanjing 1.147
Hong Kong 1.078
Beijing 1.009
Boardman 814
Nanchang 482
Los Angeles 422
Ho Chi Minh City 383
Princeton 365
Lauterbourg 363
Pavia 362
Lawrence 354
New York 352
Wilmington 347
Ann Arbor 326
Changsha 326
Helsinki 313
Shenyang 310
Hebei 309
Dearborn 304
Medford 302
Hanoi 262
Shanghai 252
Moscow 249
Jiaxing 245
Munich 218
Milan 216
Council Bluffs 202
Tianjin 196
Hangzhou 190
Johannesburg 180
Buffalo 174
Redondo Beach 163
São Paulo 135
Orem 121
Toronto 103
Brussels 99
Santa Clara 99
Turku 99
Tokyo 92
Woodbridge 86
Seattle 79
Norwalk 71
Chennai 69
Frankfurt am Main 68
Warsaw 68
London 63
Verona 63
Montreal 62
Brooklyn 61
Atlanta 56
Denver 55
Guangzhou 55
Piscataway 52
Rome 51
Kunming 49
Da Nang 47
Houston 47
Chicago 46
San Francisco 46
Falkenstein 45
Mexico City 45
Nuremberg 45
Stockholm 45
Florence 44
Jinan 43
Boston 40
Phoenix 40
Haiphong 38
Amsterdam 36
Poplar 35
Tashkent 35
Baghdad 34
Mumbai 34
Ningbo 34
Zhengzhou 34
Rio de Janeiro 33
Fairfield 32
Manchester 31
Washington 29
Des Moines 28
Brasília 26
Dhaka 25
Hefei 25
Vienna 25
Basingstoke 24
Biên Hòa 24
Quito 24
Hải Dương 23
Zurich 23
Belo Horizonte 22
New Delhi 22
Paris 22
Amman 21
Totale 26.772
Nome #
An automatic implementation of ACMG/ClinGen guidelines for constitutional Copy Number Variants annotation and interpretation 209
A comparison of eVai, CADD and VVP variant prediction results on the ICR639 hereditary cancer dataset 204
Living Materials for the Detection of Volatile Compounds to Monitor Agroindustrial Processes 189
Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management 184
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 182
Quantitative evaluation of RC-106 antitumor activity in GBM spheroids through tumor growth inhibition modeling based on cell counts data 176
A Bayesian method for clustering gene expression temporal profiles from microarray data 167
A Bayesian approach to non-parametric AUC estimation in population studies 166
A Markov decision process: screening hereditary hemochromatosis 163
A novel method for proteomic analysis of immunoglobulin light chains and attribution to a germline gene-based family 162
DIVAs: a phenotype-based machine-learning model to assess the pathogenicity of digenic variant combinations 162
Phenotypes extraction from clinical descriptions using Large Language Models 156
A non parametric population approach for selecting biomarkers of a drug action 156
Astrazioni temporali per il clustering di profili di espressione genica 155
An integrative pathology workflow to enhance molecular diagnostics in precision oncology 151
Clinical classification of myelofibrosis with myeloid metaplasia (MMM): cluster analysis of 861 patients enrolled into a nationwide prospective registry (RIMM) 148
Methods for the analysis of mass spectrometry data in proteomics 146
A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli 146
A Perl procedure for the analysis of phosphopeptide tandem mass spectra 145
Ethanol? Whey not! 144
Protein identification by peptide mass fingerprinting: a perl procedure 143
Improving protein identification by MsPI using peak intensity 143
Phosphopeptide identification: an automated Perl procedure 143
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 143
A BioBrick-compatible Vector for Allelic Replacement Using the XylE Gene as Selection Marker 143
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 142
OPTIMIZATION OF GAMMA-PGA BIOSYNTHESIS SUPPORTED BY SYNTHETIC BIOLOGY AND METABOLIC ENGINEERING STRATEGIES 142
Evaluation of the T-IDDM Project in Pavia 142
A mathematical model for assessing the glucose time course in critically ill patients 141
A Bioinformatics Approach to Explore MicroRNAs as Tools to Bridge Pathways Between Plants and Animals. Is DNA Damage Response (DDR) a Potential Target Process? 140
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 139
A bioinformatic approach to predict the cross-kingdompotential of plant miRNA in humans 139
A data mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials 138
In-Silico and in-Vivo Metabolic Engineering Strategies to Optimize Waste Bioconversion Pathways in Microbial Strains: Two Case Studies on Ethanol and Poly-Gamma-Glutamic Acid Biosynthesis 138
Integration of enzymatic data in Bacillus subtilis genome-scale metabolic model improves phenotype predictions and enables in silico design of poly-γ-glutamic acid production strains 138
A Bayesian nonparametric approach to AUC determination in population studies 137
A mathematical model to study the effects of drugs administration on tumor growth dynamics 137
A Perl procedure to improve the efficiency of the identification and characterization of phosphopeptides 136
Bottom-up engineering of biological systems through standard bricks: a modularity study on basic parts and devices 136
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 135
Movement detection from a wearable system: a deconvolution-based approach 135
A tumor growth inhibition model in drugs combination regimens 135
Precedence Temporal Networks from Gene Expression Data 134
'Indolent' myelofibrosis with myeloid metaplasia: specific clinical features and prognosis 134
A methodology for the reliable analysis of amplicon-based NGS data 134
A Perl procedure for protein identification by Peptide Mass Fingerprinting 133
Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release 133
Bottom-up design of genetic circuits: characterization and re-use of biological building blocks to engineer predictable systems 133
A procedure to decompose high resolution mass spectra 133
Methods and tools for multiscale modelling in Systems Pharmacology: a review 133
Learning Gene Regulatory Networks with an Intelligent Data Analysis Approach: An Application to the Yeast Cell Cycle 132
Biologia sintetica e standardizzazione: verso la programmazione razionale di funzioni biologiche artificiali 132
Integrative analysis of heterogeneous high-throughput transcriptomic data for promoter selection in bacterial genomes to support microbial synthetic biology 131
Analisi di dati di DNA microarray: reti di regolazione 130
Optimization of γ-PGA biosynthesis supported by synthetic biology and metabolic engineering strategies 129
Three thiamine analogues differently alter thiamine transport and metabolism in nervous tissues: an in vivo kinetic study using rats 129
CRISPR Interference Modules as Low-Burden Logic Inverters in Synthetic Circuits 128
Learning Rules with Complex Temporal Patterns in Biomedical Domains 126
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 126
Analisi di dati di DNA microarray: fondamenti, selezione di geni, classificazione 126
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 125
Genome-wide gene expression in aneurysmal aortic walls of patients with Marfan Syndrome (MFS) and Loeys-Dietz Syndromes (LDS) with known causative mutations 125
Characterization of promoter strength varying the DNA copy number from one to hundreds of copy 125
Analysis of intergenic conserved sequences in the POF critical region on X chromosome 124
Precedence Temporal Networks: a New Tool for Extracting Temporal Relationships in Gene Expression Profiles 124
Heart rate correction of the QT interval: a nonparametric individualized approach 124
Modeling myelosuppression in patients treated with anticancer drugs 124
Design and implementation of a negative feedback controller in E. coli with a bottom-up approach 124
Conversion of industrial bio-waste into biofuels through Syntetic Biology supported by flow cytometry 124
Predicting Aqueous and Intrinsic Solubility of Pharmaceutical Molecules with Neural Networks 124
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 123
Characterization of a synthetic luxR-HSL repressible promoter for the design of novel activation-repression circuits in E. coli 123
Statistical methods to detect immune responses to drug administration 122
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 122
Engineering endogenous fermentative routes in ethanologenic Escherichia coli W for bioethanol production from concentrated whey permeate 122
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 121
Optimal age and strategy for screening hereditary hemochromatosis. The answers from a Markov decision process 120
Online Microreactor Titanium Dioxide RPLC-LTQ-Orbitrap MS Automated Platform for Shotgun Analysis of (Phospho) Proteins in Human Amniotic Fluid 120
CTRL + E.: Signalling is Nothing Without Control 120
Artificial intelligence and machine learning: just a hype or a new opportunity for pharmacometrics? 120
Leveraging Two-Stage delta Global Sensitivity Analysis method to inform parameter estimation in PBPK models 119
Qualitative Representation and Clustering of Biomedical Time Series 119
Mathematical modeling of growth and death dynamics of mouse embryonic stem cells irradiated with gamma-rays 119
Precedence Temporal Networks: Extraction and Representation of Temporal Relationships in Gene Expression Profiles 118
Methods for genetic optimization of biocatalysts for biofuel production from dairy waste through synthetic biology 118
A Synthetic Close-Loop Controller Circuit for the Regulation of an Extracellular Molecule by Engineered Bacteria 118
Accurate peak list extraction from proteomic mass spectra for identification and profiling studies 118
Tumor growth modelling for drug development 117
Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter 117
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 117
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 117
A metabolic engineering approach to improve ethanol production from dairy waste by optimized Escherichia coli 117
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 116
MsPI: a tool for the analysis of peptide mass fingerprinting data 116
MsPI: A software tool for protein identification by PMF 116
BioBrick, standard assembly e registro delle parti biologiche standard 116
Characterization of promoter strength at different DNA copy numbers using RPU approach 116
Characterization of promoter strength at different DNA copy numbers using RPUs 116
SPAN-CGH (Simple Plot Analysis & Normalization for array-CGH): un software user-friendly per la visualizzazione e l'analisi statistica dei dati di array-CGH 115
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 115
Totale 13.528
Categoria #
all - tutte 155.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 0 76
2021/20221.798 46 25 91 26 23 39 52 126 95 48 297 930
2022/20235.952 651 527 83 416 567 520 17 328 2.564 36 137 106
2023/20242.397 227 459 106 163 169 505 133 171 31 64 115 254
2024/20256.165 122 590 193 202 219 225 260 412 1.536 198 707 1.501
2025/202614.864 1.263 1.168 1.866 1.775 1.959 664 2.563 553 1.227 1.043 419 364
Totale 40.722